Status: Recruiting
Eltrombopag for Chemotherapy-induced Thrombocytopenia
To evaluate the efficacy and safety of eltrombopag to treat chemotherapy-induced thrombocytopenia in solid tumors
Participants needed: 50
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Institute of Hematology & Blood Diseases Hospital, ChinaUpdated: Feb 24, 2025Locations: 1
Eligibility criteria
Aged ≥18 years old, male or female; [+7]
Those with uncontrollable primary diseases of important organs, such as extensiv... [+14]